Structural analysis by X-ray crystallography and calorimetry of a haemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum

References

1. Bailey S. 1994; The ccp4 suite: programs for protein crystallography. Acta Crystallogr D 50:760–763
   [Google Scholar]
2. Faham S., Hileman R. E., Fromm J. R., Linhardt R. J., Rees D. C. 1996; Heparin structure and interactions with basic fibroblast growth factor. Science 271:1116–1120
   [Google Scholar]
3. Finzel B. C., Clancy L. L., Holland D. R., Muchmore S. W., Watenpaugh K. D., Einspahr H. M. 1989; Crystal structure of recombinant human interleukin-1 β at 2·0 Å resolution. J Mol Biol 209:779–791
   [Google Scholar]
4. Fujinaga Y., Inoue K., Shimazaki S. 8 other authors 1994; Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization. Biochem Biophys Res Commun 205:1291–1298
   [Google Scholar]
5. Fujinaga Y., Inoue K., Watanabe S., Yokota K., Hirai Y., Nagamachi E., Oguma K. 1997; The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin. Microbiology 143:3841–3847
   [Google Scholar]
6. Fujinaga Y., Inoue K., Nomura T., Sasaki J., Marvaud J. C., Popoff M. R., Kozaki S., Oguma K. 2000; Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes. FEBS Lett 467:179–183
   [Google Scholar]
7. Habazettl J., Gondol D., Wiltscheck R., Otlewski J., Schleicher M., Holak T. A. 1992; Structure of hisactophilin is similar to interleukin-1 β and fibroblast growth factor. Nature 359:855–858
   [Google Scholar]
8. Inoue K., Fujinaga Y., Watanabe T., Ohyama T., Takeshi K., Moriishi K., Nakajima H., Oguma K. 1996; Molecular composition of Clostridium botulinum type A progenitor toxins. Infect Immun 64:1589–1594
   [Google Scholar]
9. Inoue K., Fujinaga Y., Honke K., Yokota K., Ikeda T., Ohyama T., Takeshi K., Watanabe T., Oguma K. 1999; Characterization of haemagglutinin activity of Clostridium botulinum type C and D 16S toxins, and one subcomponent of haemagglutinin (HA1). Microbiology 145:2533–2542
   [Google Scholar]
10. Inoue K., Fujinaga Y., Honke K. 7 other authors 2001; Clostridium botulinum type A haemagglutinin-positive progenitor toxin (HA⁺-PTX) binds to oligosaccharides containing Gal β 1–4GlcNAc through one subcomponent of haemagglutinin (HA1. Microbiology 147:811–819
    [Google Scholar]
11. Jahn R., Niemann H. 1994; Molecular mechanisms of clostridial neurotoxins. Ann N Y Acad Sci 733:245–255
    [Google Scholar]
12. Kraulis P. J. 1991; molscript: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 24:946–950
    [Google Scholar]
13. Lacy D. B., Tepp W., Cohen A. C., DasGupta B. R., Stevens R. C. 1998; Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5:898–902
    [Google Scholar]
14. Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M. 1993; procheck – a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283–291
    [Google Scholar]
15. Liu Y., Chirino A. J., Misulovin Z., Leteux C., Feizi T., Nussenzweig M. C., Bjorkman P. J. 2000; Crystal structure of the cysteine-rich domain of mannose receptor complexed with a sulfated carbohydrate ligand. J Exp Med 191:1105–1116
    [Google Scholar]
16. Lund B. M. 1990; Foodborne disease due to Bacillus and Clostridium species. Lancet 336:982–986
    [Google Scholar]
17. McLachlan A. D. 1979; Three-fold structural pattern in the soybean trypsin inhibitor (Kunitz. J Mol Biol 133:557–563
    [Google Scholar]
18. Merritt E. A., Bacon D. J. 1997; raster3d: photorealistic molecular graphics. Methods Enzymol 277:505–524
    [Google Scholar]
19. Montecucco C., Schiavo G. 1994; Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 13:1–8
    [Google Scholar]
20. Murzin A. G., Lesk A. M., Chothia C. 1992; β -Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 β and 1 α and fibroblast growth factors. J Mol Biol 223:531–543
    [Google Scholar]
21. Notenboom V., Boraston A. B., Williams S. J., Kilburn D. G., Rose D. R. 2002; High-resolution crystal structures of the lectin-like xylan binding domain from Streptomyces lividans xylanase 10A with bound substrates reveal a novel mode of xylan binding. Biochemistry 41:4246–4254
    [Google Scholar]
22. Ornitz D. M., Herr A. B., Nilsson M., Westman J., Svahn C. M., Waksman G. 1995; FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. Science 268:432–436
    [Google Scholar]
23. Otwinowski Z., Minor V. 1997; Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307–326
    [Google Scholar]
24. Pellegrini L., Burke D. F., von Delft F., Mulloy B., Blundell T. L. 2000; Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407:1029–1034
    [Google Scholar]
25. Perrakis A., Morris R., Lamzin V. S. 1999; Automated protein model building combined with iterative structure refinement. Nat Struct Biol 6:458–463
    [Google Scholar]
26. Rutenber E., Robertus J. D. 1991; Structure of ricin B-chain at 2·5 Å resolution. Proteins 10:260–269
    [Google Scholar]
27. Rutenber E., Ready M., Robertus J. D. 1987; Structure and evolution of ricin B chain. Nature 326:624–626
    [Google Scholar]
28. Sakaguchi G., Kozaki S., Ohishi I. 1984; Structure and function of botulinum toxins. In Bacterial Protein Toxins pp 435–443 Edited by Alouf J. E., Fehrenbach F. J., Freer J. H., Jelijasawicz J. London: Academic Press;
    [Google Scholar]
29. Shapiro R. L., Hatheway C., Swerdlow D. L. 1998; Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med 129:221–228
    [Google Scholar]
30. Sheldrick G. M., Dauter Z., Wilson K. S., Hope H., Sieker L. C. 1993; The application of direct methods and Patterson interpretation to high-resolution native protein data. Acta Crystallogr Sec D 49:18–23
    [Google Scholar]
31. Sugii S., Ohishi I., Sakaguchi G. 1977; Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes. Infect Immun 16:910–914
    [Google Scholar]
32. Swaminathan S., Eswaramoorthy S. 2000; Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat Struct Biol 7:693–699
    [Google Scholar]
33. Sweet R. M., Wright H. T., Janin J., Chothia C. H., Blow D. M. 1974; Crystal structure of the complex of porcine trypsin with soybean trypsin inhibitor (Kunitz) at 2·6-Å resolution. Biochemistry 13:4212–4228
    [Google Scholar]
34. Transue T. R., Smith A. K., Mo H., Goldstein I. J., Saper M. A. 1997; Structure of benzyl T-antigen disaccharide bound to Amaranthus caudatus agglutinin. Nat Struct Biol 4:779–783
    [Google Scholar]
35. Tsuzuki K., Kimura K., Fujii N., Yokosawa N., Indoh T., Murakami T., Oguma K. 1990; Cloning and complete nucleotide sequence of the gene for the main component of hemagglutinin produced by Clostridium botulinum type C. Infect Immun 58:3173–3177
    [Google Scholar]
36. Zhang J. D., Cousens L. S., Barr P. J., Sprang S. R. 1991; Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 β . Proc Natl Acad Sci U S A 88:3446–3450
    [Google Scholar]